Baillie Gifford & CO Dexcom Inc Transaction History
Baillie Gifford & CO
- $128 Billion
- Q2 2025
A detailed history of Baillie Gifford & CO transactions in Dexcom Inc stock. As of the latest transaction made, Baillie Gifford & CO holds 16,705,195 shares of DXCM stock, worth $1.34 Billion. This represents 1.14% of its overall portfolio holdings.
Number of Shares
16,705,195
Previous 14,179,830
17.81%
Holding current value
$1.34 Billion
Previous $968 Million
50.59%
% of portfolio
1.14%
Previous 0.87%
Shares
33 transactions
Others Institutions Holding DXCM
# of Institutions
1,106Shares Held
370MCall Options Held
5.35MPut Options Held
5.16M-
Vanguard Group Inc Valley Forge, PA48.3MShares$3.87 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.77 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$1.35 Billion0.06% of portfolio
-
Jennison Associates LLC11.5MShares$923 Million0.6% of portfolio
-
Geode Capital Management, LLC Boston, MA10.8MShares$863 Million0.07% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $31B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...